The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey

Background: Although metastatic germ cell tumor (GCT) is highly curable with initial cisplatin-based chemotherapy (CT), 20–30% of patients relapse. Salvage CT options include conventional (CDCT) and high dose chemotherapy (HDCT), however definitive comparative data remain lacking. We aimed to charac...

詳細記述

書誌詳細

主要な著者:	Esmail M. Al-Ezzi, Amer Zahralliyali, Aaron R. Hansen, Robert J. Hamilton, Michael Crump, John Kuruvilla, Lori Wood, Lucia Nappi, Christian K. Kollmannsberger, Scott A. North, Eric Winquist, Denis Soulières, Sebastien J. Hotte, Di Maria Jiang
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2023-06-01
シリーズ:	Current Oncology
主題:	relapsed germ cell tumors salvage chemotherapy conventional-dose chemotherapy high-dose chemotherapy autologous stem cell transplant
オンライン･アクセス:	https://www.mdpi.com/1718-7729/30/7/458
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!